Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents.
Cincinelli R, Musso L, Artali R, Guglielmi MB, La Porta I, Melito C, Colelli F, Cardile F, Signorino G, Fucci A, Frusciante M, Pisano C, Dallavalle S.
Cincinelli R, et al. Among authors: dallavalle s.
PLoS One. 2018 Oct 9;13(10):e0205018. doi: 10.1371/journal.pone.0205018. eCollection 2018.
PLoS One. 2018.
PMID: 30300374
Free PMC article.